Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

382
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
382
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

329
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
329
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

305
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
305
Pulse rhythm01:30

Pulse rhythm

1.2K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

216
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
216
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

416
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
416

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Describing Inconsistencies in Pediatric Labeling of Medical Devices.

JAMA network open·2025
Same author

Intellectual and Neurodevelopmental Delays in Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: Distinct Characteristics and a More Malignant Neurocardiac Phenotype.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Proceedings from The Consortium for Technology & Innovation in Pediatrics (CTIP) 2024 Annual Pediatric Device Innovation Symposium.

BMC proceedings·2025
Same author

A leadless pericardial pacemaker.

Heart rhythm·2025
Same author

Incidence and Prognosis of Surgical Heart Block in Patients with L-transposition of the Great Arteries.

Pediatric cardiology·2025
Same author

Thromboembolic Complications From Atrial Fibrillation and Atrial Flutter in Pediatrics and Young Adults: A Multicenter Study.

Journal of cardiovascular electrophysiology·2024
Same journal

Robotic Magnetic Navigation Versus Manual Catheter Ablation for Premature Ventricular Contractions: A Single-center Retrospective Cohort Study.

The Journal of innovations in cardiac rhythm management·2026
Same journal

Three Empty Bottles and a Wide QRS: Rapid Alkalinization Rescue in Propafenone Overdose.

The Journal of innovations in cardiac rhythm management·2026
Same journal

Left Bundle Branch Tachycardia: A Nightmare Confluence of Tachycardia and Bradycardia.

The Journal of innovations in cardiac rhythm management·2026
Same journal

Letter from the Editor in Chief.

The Journal of innovations in cardiac rhythm management·2026
Same journal

Right Ventricular Implantation of an Aveirâ„¢ AR Device for Bradycardia in a 90-Year-Old Woman with Atrial Fibrillation and Small Right Ventricular Dimensions.

The Journal of innovations in cardiac rhythm management·2026
Same journal

An Unusual Genetic Variant of Long QT Syndrome with Late Presentation in the Sixth Decade.

The Journal of innovations in cardiac rhythm management·2026
See all related articles

Related Experiment Video

Updated: Dec 20, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.8K

Cardiac Resynchronization Therapy in Pediatrics.

Allison C Hill1,2, Michael J Silka1,2, Yaniv Bar-Cohen1,2

  • 1Division of Cardiology, Children's Hospital Los Angeles, Los Angeles, CA, USA.

The Journal of Innovations in Cardiac Rhythm Management
|June 2, 2020
PubMed
Summary
This summary is machine-generated.

Cardiac resynchronization therapy (CRT) offers benefits for adults with heart failure. While pediatric applications are less defined due to heterogeneity, initial results for CRT in children are promising.

Keywords:
Cardiac resynchronization therapyheart failurepediatrics

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

1.5K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.2K

Related Experiment Videos

Last Updated: Dec 20, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.8K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

1.5K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.2K

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Cardiac resynchronization therapy (CRT) is established for adult heart failure with specific criteria (e.g., LBBB, low ejection fraction).
  • Pediatric heart failure presents diverse etiologies and anatomical variations, often not aligning with adult CRT guidelines.
  • Identifying suitable pediatric candidates for CRT remains challenging due to population heterogeneity.

Purpose of the Study:

  • To review current indications for CRT in pediatric patients.
  • To analyze outcomes of CRT in pediatric populations, including those with congenital heart disease.
  • To explore the potential of CRT in a heterogeneous pediatric group.

Main Methods:

  • Review of existing literature on pediatric CRT.
  • Analysis of case studies and clinical trial data for pediatric heart failure patients.
  • Comparison of adult and pediatric CRT criteria and outcomes.

Main Results:

  • Initial experiences with CRT in pediatric patients have shown encouraging outcomes across various subgroups.
  • CRT may offer benefits beyond typical adult indications in specific pediatric cases.
  • Further research is needed to refine pediatric CRT selection criteria.

Conclusions:

  • CRT is a developing therapeutic option for pediatric heart failure.
  • Tailoring CRT to pediatric-specific conditions is crucial for success.
  • Ongoing studies aim to optimize CRT utilization in children with heart conditions.